Neurosense Therapeuti -CW23NRSNWPreferred / convertible
13F holders, Q2 2025 (June 30)2holders −1
0new positions
1sold out
$0.63avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding Neurosense Therapeuti -CW23 (NRSNW) in their 13F filings, down 1 from Q1 2025. 0 opened new positions and 1 sold out. The largest holders were Clear Street LLC ($40K) and UBS Group AG ($932).
- Company
- Neurosense Therapeuti -CW23
- CUSIP
- M74240116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $2K |
All 13F filers, Q1 2025 → Q2 2025: 13,445 shares sold, net −13,445 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Clear Street LLC | — | Reduce -3.1% | 63,685 | $40K |
| UBS Group AG | — | Reduce -48.3% | 1,470 | $932 |
"% of holder's portfolio" is NRSNW's weight in each manager's 13F, not the share of Neurosense Therapeuti -CW23 the manager owns.